Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study
Article in Frontiers in Pharmacology (October 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System
Article in Expert Opinion on Drug Safety (June 2023)
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS
Article in Expert Review of Clinical Pharmacology (May 2023)